- Home
- Products
- Customized ADCs
- CD19
- Anti-CD19 (clone hBU12)-vc-PAB-MMAE ADC
Anti-CD19 (clone hBU12)-vc-PAB-MMAE ADC (CAT#: ADC-W-119)
This ADC product is comprised of an anti-CD19 monoclonal antibody conjugated (clone hBU12) via a vc-PAB linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- CD19
- Alternative Names
- CD19; CD19 molecule; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4;
- Target Entrez Gene ID
- 930
- Target UniProt ID
- P15391
- Overview
- Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
- Overview
- Anti-CD19-antibody
- Species Reactivity
- Human
- Name
- VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
- Description
- Peptide linkers, belonging to Enzymatically cleavable linkers, combine greater systemic stability with rapid enzymatic release of the drug in the target cell. The scission of peptidic bonds relies on lysosomal proteolytic enzymes, which have very low activities in blood due to endogenous inhibitors and the unfavorably high pH value of blood.
- Name
- MMAE (Monomethyl auristatin E)
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-SOST (Blosozumab)-SPDB-DM4 ADC (CAT#: ADC-W-1767)
- Anti-MUC16 (clone 3A5)-VC-MMAE ADC (CAT#: ADC-W-022)
- Anti-APP (Crenezumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-690)
- Anti-FCER2 (Gomiliximab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1145)
- Anti-ERBB3 (Patritumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1121)
- Anti-FLT1 (Icrucumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1151)
- Anti-CD28 (lumretuzumab)-SMCC-DM1 ADC (CAT#: ADC-W-2276)
- Anti-BSG (Gavilimomab)-MC-MMAF ADC (CAT#: ADC-W-718)
- Anti-CTLA4 (Ticilimumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1007)
- Anti-IgE Fc (Talizumab)-SMCC-DM1 ADC (CAT#: ADC-W-2150)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-119. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
CAT# | Product Name | Linker | Payload |
ADC-W-776 | Anti-CD19 (Blinatumomab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-2520 | Anti-CD19 (Denintuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
ADC-W-2516 | Anti-CD19 (Denintuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-493 | Anti-CD19 (clone huB4)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
ADC-W-779 | Anti-CD19 (Blinatumomab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
CAT# | Product Name | Linker | Payload |
ADC-W-117 | Anti-ERBB2 (Trastuzumab)-vc-PAB-MMAE ADC | VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
ADC-W-211 | Anti-EGFR (Cetuximab)-VC-PAB-MODO ADC | VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl) | MODO (monomethyldolastatin) |
CAT# | Product Name | Linker | Payload |
ADC-AA-021 | anti-MIgG(Fc)-C-MMAE ADC | Cleavable linkers | MMAE (Monomethyl auristatin E) |
ADC-W-465 | Anti-TNFRSF8 (Brentuximab)-VC-PAB-MMAE ADC | VC-PAB (valine-citrulline with PAB) | MMAE (Monomethyl auristatin E) |
ADC-AA-052 | Protein A-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
ADC-W-529 | Anti-F3 (TF-011)-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
ADC-AA-003 | anti-HIgG(Fc)-C-MMAE ADC | Cleavable linkers | MMAE (Monomethyl auristatin E) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.